FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3201769695> ?p ?o ?g. }

• W3201769695 abstract "Different factors are used as predictors of unfavorable clinical outcomes in B-Cell Acute Lymphoblastic Leukemia (B-ALL) patients. However, new prognostic markers are needed in order to allow treatment to be more accurate, providing better results and an improved quality of life. In the present study, we have characterized the profile of bone marrow soluble mediators as possible biomarkers for risk group stratification and minimal residual disease (MRD) detection during induction therapy. The study featured 47 newly-diagnosed B-cell acute lymphoblastic leukemia (B-ALL) patients that were categorized into subgroups during induction therapy according to risk stratification at day 15 [Low Risk (LR), Low Risk increasing to High Risk (LR→HR) and High Risk (HR)] and the MRD detection on day 35 (MRD(-) and MRD(+)). Soluble immunological mediators (CXCL8, CCL2, CXCL9, CCL5, CXCL10, IL-1β, IL-6, TNF, IFN-γ, IL-17A, IL-4, IL-5, IL-10 and IL-2) were quantified by cytometric bead array and ELISA. Our findings demonstrated that increased levels of CCL5, IFN-γ and IL-2 at baseline appeared as putative candidates of good prognosis in LR and MRD(-) subgroups, while CCL2 was identified as a consistent late biomarker associated with poor prognosis, which was observed on D35 in HR and MRD(+) subgroups. Furthermore, apparently controversial data regarding IL-17A and TNF did not allow the definition of these molecules as either positive or negative biomarkers. These results contribute to the search for novel prognostic indicators, and indicate the potential of bone marrow soluble mediators in prognosis and follow-up of B-ALL patients during induction therapy." @default.
• W3201769695 created "2021-10-11" @default.
• W3201769695 creator A5014569390 @default.
• W3201769695 creator A5015492199 @default.
• W3201769695 creator A5016496013 @default.
• W3201769695 creator A5017523406 @default.
• W3201769695 creator A5021876583 @default.
• W3201769695 creator A5022976564 @default.
• W3201769695 creator A5023021730 @default.
• W3201769695 creator A5043081731 @default.
• W3201769695 creator A5047064629 @default.
• W3201769695 creator A5060330494 @default.
• W3201769695 creator A5081965661 @default.
• W3201769695 creator A5083367922 @default.
• W3201769695 creator A5085880705 @default.
• W3201769695 date "2021-09-27" @default.
• W3201769695 modified "2023-10-14" @default.
• W3201769695 title "Bone Marrow Soluble Immunological Mediators as Clinical Prognosis Biomarkers in B-Cell Acute Lymphoblastic Leukemia Patients Undergoing Induction Therapy" @default.
• W3201769695 cites W1262816711 @default.
• W3201769695 cites W1970808497 @default.
• W3201769695 cites W1972019822 @default.
• W3201769695 cites W1992124982 @default.
• W3201769695 cites W2001032385 @default.
• W3201769695 cites W2013167503 @default.
• W3201769695 cites W2026028987 @default.
• W3201769695 cites W2027584655 @default.
• W3201769695 cites W2041122217 @default.
• W3201769695 cites W2041634576 @default.
• W3201769695 cites W2042450855 @default.
• W3201769695 cites W2044867979 @default.
• W3201769695 cites W2048431284 @default.
• W3201769695 cites W2059999488 @default.
• W3201769695 cites W2074181164 @default.
• W3201769695 cites W2074654703 @default.
• W3201769695 cites W2082685557 @default.
• W3201769695 cites W2088619685 @default.
• W3201769695 cites W2091117045 @default.
• W3201769695 cites W2116378201 @default.
• W3201769695 cites W2127877679 @default.
• W3201769695 cites W2130794319 @default.
• W3201769695 cites W2157414462 @default.
• W3201769695 cites W2606238758 @default.
• W3201769695 cites W2606712924 @default.
• W3201769695 cites W2617691667 @default.
• W3201769695 cites W2725970815 @default.
• W3201769695 cites W2747254185 @default.
• W3201769695 cites W2949498852 @default.
• W3201769695 cites W2963347496 @default.
• W3201769695 cites W3008334220 @default.
• W3201769695 cites W3018590946 @default.
• W3201769695 cites W3165585845 @default.
• W3201769695 cites W3176268065 @default.
• W3201769695 cites W3183770291 @default.
• W3201769695 doi "https://doi.org/10.3389/fonc.2021.696032" @default.
• W3201769695 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8503185" @default.
• W3201769695 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34646761" @default.
• W3201769695 hasPublicationYear "2021" @default.
• W3201769695 type Work @default.
• W3201769695 sameAs 3201769695 @default.
• W3201769695 citedByCount "3" @default.
• W3201769695 countsByYear W32017696952022 @default.
• W3201769695 crossrefType "journal-article" @default.
• W3201769695 hasAuthorship W3201769695A5014569390 @default.
• W3201769695 hasAuthorship W3201769695A5015492199 @default.
• W3201769695 hasAuthorship W3201769695A5016496013 @default.
• W3201769695 hasAuthorship W3201769695A5017523406 @default.
• W3201769695 hasAuthorship W3201769695A5021876583 @default.
• W3201769695 hasAuthorship W3201769695A5022976564 @default.
• W3201769695 hasAuthorship W3201769695A5023021730 @default.
• W3201769695 hasAuthorship W3201769695A5043081731 @default.
• W3201769695 hasAuthorship W3201769695A5047064629 @default.
• W3201769695 hasAuthorship W3201769695A5060330494 @default.
• W3201769695 hasAuthorship W3201769695A5081965661 @default.
• W3201769695 hasAuthorship W3201769695A5083367922 @default.
• W3201769695 hasAuthorship W3201769695A5085880705 @default.
• W3201769695 hasBestOaLocation W32017696951 @default.
• W3201769695 hasConcept C126322002 @default.
• W3201769695 hasConcept C13373296 @default.
• W3201769695 hasConcept C143998085 @default.
• W3201769695 hasConcept C203014093 @default.
• W3201769695 hasConcept C2776914184 @default.
• W3201769695 hasConcept C2778461978 @default.
• W3201769695 hasConcept C2779823535 @default.
• W3201769695 hasConcept C2780007613 @default.
• W3201769695 hasConcept C2781197716 @default.
• W3201769695 hasConcept C55493867 @default.
• W3201769695 hasConcept C71924100 @default.
• W3201769695 hasConcept C86803240 @default.
• W3201769695 hasConceptScore W3201769695C126322002 @default.
• W3201769695 hasConceptScore W3201769695C13373296 @default.
• W3201769695 hasConceptScore W3201769695C143998085 @default.
• W3201769695 hasConceptScore W3201769695C203014093 @default.
• W3201769695 hasConceptScore W3201769695C2776914184 @default.
• W3201769695 hasConceptScore W3201769695C2778461978 @default.
• W3201769695 hasConceptScore W3201769695C2779823535 @default.
• W3201769695 hasConceptScore W3201769695C2780007613 @default.
• W3201769695 hasConceptScore W3201769695C2781197716 @default.
• W3201769695 hasConceptScore W3201769695C55493867 @default.
• W3201769695 hasConceptScore W3201769695C71924100 @default.
• W3201769695 hasConceptScore W3201769695C86803240 @default.

• next